8. Bibliographie

1. GOLOMB B. A. (1995). Paradox of placebo effect. Nature 375(6532): 530

2. SCHOEMAKER J. H. (1995). Benefits of placebos. Nature 377: 98

3. KNUDTSON M. L., WYSE, D. G., et al. (2002). Chelation therapy for ischemic heart disease : a randomized controlled trial. JAMA 287: 481-6

4. STRASSBERG D. (2002). Chelation therapy for patients with ischemic heart disease (letter). JAMA 287: 2077

5. BELL S. A. (2002). Chelation therapy for patients with ischemic heart disease (letter). JAMA 287: 2077

6. KAUFMANN P. A., GNECCHI-RUSCONE, T., et al. (2000). Coronary heart disease in smokers : vitamin C restores coronary microcirculation function. Circulation 102: 1233-8

7. SCHECHTER M., SHARIR, M., et al. (2000). Oral magnesium therapy improves endothelial function in patients with coronary artery disease. Circulation 102: 2353-8

8. LEMOINE P. (1998). Pharmacologie du placebo. http://www.med.univ-rennes1.fr/etud/pharmaco/placebo.htm.

9. LYONS D. (1995). Benefits of placebos. Nature 378: 125

10. JACKSON K., YOUNG, D., et al. (2000). Drug-excipient interactions and their affect on absorption. Pharmaceutical Science and Technology Today 3(10): 336-45

11. GOLOMB B. A. (1996). Using placebos. Nature 379(6568): 765

12. BIAM (1999). Dissolvurol. http://www2.biam2.org/www/Spe1483.html